2023-01-31 11:00:00

good natured Products Inc. Announces Preliminary Unaudited Results for the Fourth Quarter and Full Year Ended...

Logo NewsFileCorp

Vancouver, British Columbia--(Newsfile Corp. - January 31, 2023) - good natured Products Inc. (TSXV: GDNP) (OTCQX: GDNPF) (the "Company" or "good natured®"), a North American leader in plant-based products, today announced preliminary revenue and gross margin estimates for the three months ended December 31, 2022 ("Q4 2022") and year ended December 31, 2022 ("FY2022").

Revenue for Q4 2022 is anticipated to be $20.9 million to $22.9 million, which is flat to a decrease of 8.6% compared to $22.9 million for the three months ended December 31, 2021 ("Q4 2021"). Revenue for FY2022 is anticipated to be $98.6 million to $100.6 million, an increase of approximately 61% to 65%, compared to $61.1 million for the year ended December 31, 2021 ("FY2021").

Variable gross margin, a non-GAAP measure1, for Q4 2022 is anticipated between 31.5% and 33.5% compared to 30.5% for Q4 2021. Gross margin is estimated between 24.0% and 26.0% for Q4 2022 compared to 23.3% for Q4 2021. Variable gross margin for FY2022 is anticipated to be between 31.0% and 33.0%, compared to 32.2% for FY2021. Gross margin for FY2022 is anticipated between 24.0% and 26.0%, compared to 25.6% for FY2021.

The Company's cash balance at December 31, 2022 is anticipated to be approximately $11.8 million, compared to $10.6 million for FY2021.

The Company plans to release full FY2022 results in April 2023.

"Our team and partners delivered record annual revenue and stable comparative gross margins in the face of very challenging macroeconomic conditions in 2022. This is a testament to the Company's ability to successfully adjust to a changing operating environment and I want to thank all our team members, partners and customers for their support over the past year," stated Paul Antoniadis, CEO of good natured®. "Demand for sustainable, earth-friendly packaging, especially within staple goods categories like food and medical, remained resilient, and our sales pipeline continues to be very robust in these areas. As we'd anticipated, industrial product sales remained soft through the fourth quarter as customers worked through high inventory levels in the face of continued fluctuation in demand levels."

The preliminary results set forth above are based on an initial review of the Company's financial results for Q4 2022 and FY2022 and are subject to change. Final reported results could differ from these preliminary results following the completion of year-end accounting procedures, final adjustments and other developments arising between now and the time that the Company's financial results are finalized, and such changes could be material. The Company's independent auditor, Deloitte LLP, has not audited, reviewed, or performed any procedures with respect to the accompanying preliminary financial results and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto. The preliminary results have been prepared by, and are the responsibility of, the Company's management, and were approved by management on January 30, 2023. In addition, these preliminary results are not a comprehensive statement of the Company's financial results for Q4 2022 and FY2022. They should not be viewed as a substitute for audited financial statements prepared in accordance with International Financial Reporting Standards and are not necessarily indicative of the Company's results for any future period.

The good natured® corporate profile can be found at: investor.goodnaturedproducts.com.

About good natured Products Inc.
good natured® is passionately pursuing its goal of becoming North America's leading earth-friendly product company by offering the broadest assortment of plant-based products made from rapidly renewable resources instead of fossil fuels. The Company is focused on making it easy and affordable for business owners and consumers to shift away from petroleum to better everyday products® that use more renewable materials, less fossil fuel, and no chemicals of concern.

good natured® offers over 400 products and services through wholesale, direct to business, and retail channels. From plant-based home organization products to certified compostable food containers, bio-based industrial supplies and medical packaging, the Company is focused on making plant-based products more readily accessible to people as a means to create meaningful environmental and social impact.

For more information: goodnaturedproducts.com.

On behalf of the Company:
Paul Antoniadis - Executive Chair & CEO
Contact: 1-604-566-8466

Investor Contact:
Spencer Churchill
Investor Relations
1-877-286-0617 ext. 113

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibilities for the adequacy or accuracy of this release.

Non-GAAP financial measures

We have included in this press release a discussion of the Company's variable gross margin, a non-GAAP measure, for Q4 2022, Q4 2021, FY2022, and FY2021 to provide, what management believes, is a meaningful comparison of the Company's performance in Q4 2022 and FY2022. In this news release, variable gross margin is gross margin excluding fixed production costs such as depreciation, repairs and maintenance, utilities, and similar overhead items. The use of variable gross margin by management allows for evaluation of the core aspects of the Company's profit margin as certain fixed production costs that are outside the Company's control are excluded. Variable gross margin does not have a standardized meaning, and therefore may not be comparable to similar measures presented by other issuers.

The following table provides a reconciliation of preliminary and historic gross margin to preliminary and historic variable gross margin (expressed in thousands of dollars)

Q4 2022 Q4 2021 FY2022 FY2021
Low end Upper end Low end Upper end
Revenue 20,900 22,900 22,860 98,600 100,600 61,132
Cost of product revenue            
Variable cost of product (14,317 ) (15,229 ) (15,880 ) (68,034 ) (67,402 ) (41,462 )
Variable gross profit 6,584 7,672 6,980 30,566 33,198 19,670
Variable gross margin % 31.5% 33.5% 30.5% 31.0% 33.0% 32.2%
Factory overhead and depreciation (1,568 ) (1,718 ) (1,650 ) (6,902 ) (7,042 ) (4,033 )
Gross profit 5,016 5,954 5,330 23,664 26,156 15,637
Gross margin % 24.0% 26.0% 23.3% 24.0% 26.0% 25.6%


Cautionary Statement Regarding Forward-Looking Information

Information regarding the release of Q4 2022 and FY2022 preliminary revenue, gross margin and cash balance contained in this press release may constitute forward-looking information within the meaning of securities laws. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

The financial outlook provided in this press release is provided to provide early guidance on the fourth quarter financial performance of the Company and readers are cautioned that this information may not be appropriate for any other purpose. In preparing the financial outlook, the Company completed an initial review of operations for the three and twelve months ended December 31, 2022, however actual results may differ materially from the financial outlook provided in this press release as the financial outlook has not been audited or reviewed. When relying on the Company's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed that the material factors referred to herein will not cause such forward-looking statements and information to differ materially from actual results or events. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Other than as required under securities laws, we do not undertake to update this information at any particular time.

Forward-looking information contained in this news release is based on our current estimates, expectations, and projections, which we believe are reasonable as of the current date. The reader should not place undue importance on forward-looking information and should not rely upon this information as of any other date. All forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

1 For more information regarding non-GAAP measures included in this news release, please refer to “Non-GAAP financial measures” below

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152974

Continue read on newsfilecorp.com

Logo Benzinga
Business / FinanceBy Business Wire2023-01-30 12:05:00
Flora will host a webcast discussing 2023 guidance and recapping 2022 milestones at 4:30 pm ET on January 30, 2023. Register and join here. Flora Growth...

Logo GlobeNewswire
SciencePress Release2023-01-30 13:00:00
Cash Receipts Q2 2022 to Year to Date MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, Company,...

Logo PR Newswire
In 2023, the certified-organic mattress and bedding manufacturer is marking a significant milestone with product launches, store openings and promotions...

Logo RTTNews
Business / FinanceBy Rtt News Staff Writer2023-01-30 12:26:28
Flora Growth Corp. ( FLGC ) announced revenue guidance of $90 million to $105 million for fiscal 2023. The company noted that the revenue guidance reflects...

Logo PR Newswire
TORONTO, Jan. 30, 2023 /CNW/ - Canaccord Genuity Group Inc. (TSX: CF) is scheduled to release its third quarter fiscal 2023 results and supplementary...

Logo Nasdaq
Business / FinanceBy Mt Newswires2023-01-30 14:18:57
Health care stocks were in the red pre-bell Monday. The Health Care Select Sector SPDR Fund ( XLV ) was 0.3% lower and the iShares Biotechnology ETF ( IBB )...

Logo NewsFileCorp
Press Release2023-01-30 13:30:00
Denver, Colorado--(Newsfile Corp. - January 30, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and Hemp oil company ("CBDD") and a producer,...

Logo PR Newswire
TechnologyPress Release2023-01-30 21:10:00
CHARLESTON, S.C., Jan. 30, 2023 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, will report its...

Logo PR Newswire
DUBLIN, Jan. 30, 2023 /PRNewswire/ -- Research and Markets The "Global Bioplastics Market: Analysis By Production Capacity, By Type, By Application, By...

Logo PR Newswire
LEHI, Utah, Jan. 30, 2023 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple" or the "Company"), a comfort innovation company known for creating...

Logo PR Newswire
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Creatd, Inc. (OTCQB: CRTD) ("Creatd" or the "Company"), a creator-first technology company, today announced that it...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-31 02:26:00
The Company has also signed an LOI with Berlin-based health and life science company Sanity Group to better take advantage of potential German adult-use...

Logo PR Newswire
HealthPress Release2023-01-31 04:55:00
Revenue Up 800% Year-over-Year TORONTO, Jan. 30, 2023 /PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-31 09:54:13
Companies Reporting Before The Bell Biophytis BPTS is projected to report earnings for its first quarter. UBS Gr UBS is likely to report quarterly earnings...

Logo PR Newswire
TSXV : GMIN OTCQX : GMINF BROSSARD, QC, Jan. 30, 2023 /PRNewswire/ - G Mining Ventures Corp. (" GMIN " or the " Corporation ") (TSXV: GMIN) (OTCQX: GMINF) is...

Logo EIN Presswire
SciencePress Release2023-01-30 12:00:00
2Blades logo GEMS logo New study on losses from crop diseases highlights need for greater R&D investment

Logo GlobeNewswire
SciencePress Release2023-01-30 21:10:00
Lille (France ), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 30, 202 3 GENFIT (Nasdaq and Euronext: GNFT), a late-stage...

Logo PR Newswire
MEXICO CITY, Jan. 30, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it...

Logo PR Newswire
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Limited Duration Preferred and Income Fund, Inc....

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-30 12:30:00
Ease Labs Pharma, a global pharmaceutical company headquartered in Brazil, has received regulatory approval from the Brazilian Health Regulatory Agency...